115 related articles for article (PubMed ID: 15958310)
1. [Dynamic monitoring of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation by soluble HLA-I antigen detection].
Xia R; Qiu HY; Zhang WP; Cao Q; Lan JC; Wen HS; Wang JM
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):687-90, 695. PubMed ID: 15958310
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
3. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
[TBL] [Abstract][Full Text] [Related]
4. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
[TBL] [Abstract][Full Text] [Related]
5. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
7. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
9. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
[TBL] [Abstract][Full Text] [Related]
11. Detection of soluble HLA class I antigens by ELISA and determination of its reference value in population of Guangdong province.
Wu T; Lan JC; Zhang H; Wang CR; Mao GC
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):931-3. PubMed ID: 12377624
[TBL] [Abstract][Full Text] [Related]
12. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
13. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.
Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH
Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536
[TBL] [Abstract][Full Text] [Related]
14. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
15. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
[TBL] [Abstract][Full Text] [Related]
16. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
17. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
[TBL] [Abstract][Full Text] [Related]
20. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
